Callan Family Office’s Hologic HOLX Stock Holding History

Callan Family Office’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,305	Closed	-$325K	–	1241
2026 Q1	$325K	Sell	4,305 -193	-4%	-$14.5K	0.01%	904
2025 Q4	$335K	Buy	+4,498	New	+$329K	0.01%	895

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Callan Family Office's HOLX Position: Q2 2026 in Review

Callan Family Office sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,305 shares — an estimated $325K sold.

Callan Family Office first reported a position in HOLX in Q4 2025 and held it in 2 quarters. The position peaked at $335K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Callan Family Office reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Callan Family Office sold 4,305 Hologic shares in Q2 2026, an estimated $325K.
Callan Family Office first reported a position in Hologic in Q4 2025 and held it in 2 quarters.
Callan Family Office's Hologic position peaked at $335K in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.